Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses.

Fadia Tohme Shaya Krystal SingRobert MilamFasahath HusainMichael A Del AguilaMiraj Y Patel

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)

Ezetimibe, when added to statin therapy, provided a modest additional reduction in LDL-C compared with statin monotherapy. However, this may not be sufficient for some patients with ASCVD who have especially high LDL-C levels despite optimal statin therapy.

Keyphrases

cardiovascular disease
low density lipoprotein
meta analyses
coronary artery disease
systematic review
type diabetes
randomized controlled trial
cardiovascular events
stem cells
clinical trial
fatty acid
metabolic syndrome
smoking cessation
study protocol